Technetium and gallium derived radiopharmaceuticals: Comparing and contrasting the chemistry of two important radiometals for the molecular imaging era

Mark D. Bartholomä, Anika S. Louie, John F. Valliant, Jon Zubieta

Research output: Contribution to journalArticle

213 Scopus citations

Abstract

A comparison of two radiometals, technetium and gallium derived radiopharmaceuticals is presented. 99mTc is available from a commercial generator technology where a parent isotope (99Mo) is loaded onto an alumina column and the desired daughter is isolated by passing a saline solution through the system. Technetium is a transition metal that presents a major challenge with respect to designing radiopharmaceuticals that have suitable in vivo properties. While the technetium- and rhenium- organohydrazino cores display the advantages of facile preparation and chemical robustness, the intimate details of the chemistry are complex, dependent upon reaction conditions and the presence of coligands. Gallium-67 is cyclotron produced by the 68Zn (p, 2n)-67Ga reaction in which a thin layer of enriched 68Zn is electrochemically plated on an appropriate metal target. With advanced molecular imaging there is an increasing demand for new agents and a need for innovative radiopharmaceutical discovery and design paradigms.

Original languageEnglish (US)
Pages (from-to)2903-2920
Number of pages18
JournalChemical Reviews
Volume110
Issue number5
DOIs
StatePublished - May 12 2010

ASJC Scopus subject areas

  • Chemistry(all)

Fingerprint Dive into the research topics of 'Technetium and gallium derived radiopharmaceuticals: Comparing and contrasting the chemistry of two important radiometals for the molecular imaging era'. Together they form a unique fingerprint.

  • Cite this